Bank of Montreal
GALT icon

Bank of Montreal’s Galectin Therapeutics GALT Stock Holding History

Bank of Montreal’s Portfolio GALT Stock Details GALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-20,432
Closed -$80K – 3619
2021
Q3 		$80K Hold
20,432
– – ﹤0.01% 3487
2021
Q2 		$83K Sell
20,432
-897
-4% -$3.19K ﹤0.01% 3357
2021
Q1 		$53K Buy
21,329
+15,606
+273% +$35K ﹤0.01% 3665
2020
Q4 		$12K Buy
5,723
+3,903
+214% +$10.2K ﹤0.01% 4610
2020
Q3 		$5K Sell
1,820
-1,179
-39% -$3.3K ﹤0.01% 4419
2020
Q2 		$8K Buy
2,999
+2,899
+2,899% +$7.29K ﹤0.01% 4268
2020
Q1 		$0 Sell
100
-90,160
-100% -$219K ﹤0.01% 4304
2019
Q4 		$258K Buy
90,260
+1,447
+2% +$5.03K ﹤0.01% 3025
2019
Q3 		$326K Buy
88,813
+78,721
+780% +$285K ﹤0.01% 2653
2019
Q2 		$42K Sell
10,092
-92,408
-90% -$400K ﹤0.01% 3780
2019
Q1 		$524K Sell
102,500
-209,100
-67% -$1M ﹤0.01% 2275
2018
Q4 		$1.07M Buy
311,600
+145,100
+87% +$693K ﹤0.01% 1856
2018
Q3 		$1M Buy
166,500
+91,000
+121% +$501K ﹤0.01% 1996
2018
Q2 		$480K Buy
+75,500
New +$368K ﹤0.01% 2357
2016
Q2 		– Sell
-100
Closed – – 4163
2016
Q1 		$0 Hold
100
– – ﹤0.01% 4259
2015
Q4 		$0 Hold
100
– – ﹤0.01% 4298
2015
Q3 		$0 Hold
100
– – ﹤0.01% 4046
2015
Q2 		$0 Hold
100
– – ﹤0.01% 3991
2015
Q1 		$0 Hold
100
– – ﹤0.01% 4053
2014
Q4 		$0 Buy
+100
New +$442 ﹤0.01% 4065

Other funds holding GALT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GWM
Geneos Wealth Management Englewood, Colorado $4.31B AUM 18.36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCB
Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of Montreal's GALT Position: Q4 2021 in Review

Bank of Montreal sold out of Galectin Therapeutics (GALT) in Q4 2021, closing a stake of 20,432 shares — an estimated $80K sold.

Bank of Montreal first reported a position in GALT in Q4 2014 and held it in 20 quarters. The position peaked at $1.07M in Q4 2018. 55 funds tracked by Wall St. Rank hold GALT as of Q4 2021.

  • Bank of Montreal reported no remaining Galectin Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Bank of Montreal sold 20,432 Galectin Therapeutics shares in Q4 2021, an estimated $80K.
  • Bank of Montreal first reported a position in Galectin Therapeutics in Q4 2014 and held it in 20 quarters.
  • Bank of Montreal's Galectin Therapeutics position peaked at $1.07M in Q4 2018.
  • 55 funds tracked by Wall St. Rank held Galectin Therapeutics as of Q4 2021.

Based on Bank of Montreal's 13F filing for Q4 2021, filed 11 Feb 2022.